BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

CMS’ price negotiations take two: Ozempic, Xtandi among 15 drugs chosen
In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS) laid out the latest 15...

More in BioWorld

BioWorld MedTech

Boston Sci reports good data for Farapulse, Watchman afib systems
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the...

More in BioWorld MedTech

BioWorld Science

Huntington’s neurodegeneration starts at 150 repeat expansions
Having 35 copies of the CAG triplet in the gene that causes Huntington’s disease is not a problem. Inheriting 40 could be a sign that goes unnoticed for decades, until...

More in BioWorld Science

BioWorld Asia

Abbvie and Simcere enter a $1B T-cell engager deal
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare Conference...

More in BioWorld Asia

BioWorld Insider Podcast

The BioWorld Insider podcast is a monthly dive into the business and science of drug development. Conversations with CEOs and BioWorld analysts in the past 12 months have included a wide range of chats with experts who are shaping the future.